Coronary disease & ACSRandomised controlled trial

Endotype-informed therapy and effects on illness perception and psychological health in patients with chest pain and no obstructive coronary artery disease

Eur Heart J Qual Care Clin OutcomesPublished

  • prospective, multicentre, randomized controlled superiority trial

Authors' conclusion

In patients with ANOCA, non-invasive CMR-guided endotyping linked to targeted therapy resulted in substantial and sustained improvements in illness perception and psychological health, highlighting the importance of diagnostic clarification in addressing the psychological burden of this condition.

Study context

Population
Patients with chest pain undergoing invasive coronary angiography showing no obstructive coronary artery disease (ANOCA)randomized, mean age 63.3 years, 50.4% female · control 126 · intervention 124
Participants
250 patients
Comparison
intervention vs control
  • interventionn = 124
  • controln = 126

Primary result

Brief Illness Perception Questionnaire (BIPQ) score (illness perception) · 6 months

Adjusted mean difference

−8.67

95% CI −12.04 to −5.30

P < 0.001

intervention vs control
adjusted mean difference −8.67 (95% CI −12.04 to −5.30); P < 0.001

As reported in the abstract

Further findings

Outcomeadjusted mean difference (95% CI)P value
BIPQ score (illness perception) · 12 months · lower in intervention−10.80 (−14.27 to −7.33)P < 0.001
PHQ-4 score (psychological health) · 6 months · reduced in intervention−0.88 (−1.19 to −0.57)P < 0.001
PHQ-4 score (psychological health) · 12 months · reduced in intervention−0.97 (−1.29 to −0.65)P < 0.001

Original publication

Endotype-informed therapy and effects on illness perception and psychological health in patients with chest pain and no obstructive coronary artery disease. Eur Heart J Qual Care Clin Outcomes. Published 4 June 2026. doi:10.1093/ehjqcco/qcag081

Summarised from the published abstract; every number is checked against it